Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.23T
Market cap1.23T
Price-Earnings ratio
40.36
Price-Earnings ratio40.36
Dividend yield
0.58%
Dividend yield0.58%
Average volume
3.19M
Average volume3.19M
High today
$1,231.94
High today$1,231.94
Low today
$1,180.00
Low today$1,180.00
Open price
$1,185.00
Open price$1,185.00
Volume
3.01M
Volume3.01M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,229.44, giving the company a market capitalization of 1.23T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.

On 2026-08-10, Eli Lilly(LLY) stock traded between a low of $1,180.00 and a high of $1,231.94. Shares are currently priced at $1,229.44, which is +4.2% above the low and -0.2% below the high.

The Eli Lilly(LLY)'s current trading volume is 3.01M, compared to an average daily volume of 3.19M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.

LLY News

The Motley Fool 43m
Why Eli Lilly Topped the Market Today

Eli Lilly (LLY +3.90%) had a fine start to the trading week. On Monday, its stock rose by almost 4% on news that a key European regulator had approved one of it...

Why Eli Lilly Topped the Market Today
TipRanks 3h
MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

Britain’s Medicines and Healthcare products Regulatory Agency has authorized Eli Lilly’s (LLY) orforglipron, or Foundayo, making the UK the first country in Eur...

Investing.com 4h
Eli Lilly’s weight-loss pill secures first European nod in Britain By Reuters - Investing.com

...

Eli Lilly’s weight-loss pill secures first European nod in Britain By Reuters - Investing.com

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
12.9%
Sell
6.5%

More LLY News

TipRanks 4h
Five-Star Analyst Raises Price Target on Eli Lilly Stock After Blowout Earnings

A five-star rated analyst at BMO Capital (BMO) raised his price target on Eli Lilly’s (LLY) stock after the pharmaceutical company’s blowout second-quarter fina...

Investor's Business Daily 7h
Amazon, IBD Stock Of The Day, Rides Cloud Momentum To $3 Trillion Milestone

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views 8/08/2026 Among the best stocks in earnings performance, highly rated...

Amazon, IBD Stock Of The Day, Rides Cloud Momentum To $3 Trillion Milestone
Barron's 18h
Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs

Markets Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs In this article NVDA LLY DIS AMD NVO Eli Lilly, Disney and Nvidia have asserted their...

Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs
Simply Wall St 1d
Eli Lilly Stock Could Be 28% Undervalued As Guidance Rises

Eli Lilly stock has climbed very sharply over the past five years, yet the current valuation checks send a more measured signal, with the Discounted Cash Flow (...

Eli Lilly Stock Could Be 28% Undervalued As Guidance Rises
Nasdaq 2d
When Leverage Goes Wrong on Wall Street

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium and Lou Whiteman, along with Motley Fool analyst Jason Moser, discus...

When Leverage Goes Wrong on Wall Street
Nasdaq 2d
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Key Points Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeutics' leading GLP-1 candidate looks very promisi...

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?
Nasdaq 3d
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Key Points Eli Lilly should request approval for retatrutide early next year. This medicine could help the company expand the weight loss market. The drugmak...

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.